🚀 VC round data is live in beta, check it out!
Quantum BioPharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Quantum BioPharma and similar public comparables like Exact Therapeutics, Citius Pharmaceuticals, DexTech Medical, Anebulo Pharmaceuticals and more.
Quantum BioPharma Overview
About Quantum BioPharma
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
Founded
1994
HQ
Employees
7
Website
Sectors
Financials (LTM)
EV
$18M
Quantum BioPharma Financials
Quantum BioPharma reported last 12-month revenue of —.
In the same LTM period, Quantum BioPharma generated — in gross profit and had net loss of ($22M).
Revenue (LTM)
Quantum BioPharma P&L
In the most recent fiscal year, Quantum BioPharma reported revenue of — and EBITDA of ($26M).
Quantum BioPharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($26M) | XXX | XXX | XXX |
| Net Profit | ($22M) | XXX | ($26M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Quantum BioPharma Stock Performance
Quantum BioPharma has current market cap of $19M, and enterprise value of $18M.
Market Cap Evolution
Quantum BioPharma's stock price is $3.25.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18M | $19M | -8.6% | XXX | XXX | XXX | $-4.49 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQuantum BioPharma Valuation Multiples
Quantum BioPharma trades at (0.7x) EV/EBITDA.
EV / Revenue (LTM)
Quantum BioPharma Financial Valuation Multiples
As of April 11, 2026, Quantum BioPharma has market cap of $19M and EV of $18M.
Equity research analysts estimate Quantum BioPharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Quantum BioPharma has a P/E ratio of (0.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19M | XXX | $19M | XXX | XXX | XXX |
| EV (current) | $18M | XXX | $18M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.7x) | XXX | XXX | XXX |
| EV/EBIT | (1.3x) | XXX | (1.2x) | XXX | XXX | XXX |
| P/E | (0.9x) | XXX | (0.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Quantum BioPharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Quantum BioPharma Margins & Growth Rates
Quantum BioPharma's revenue in the last fiscal year grew by —.
Quantum BioPharma's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $2.2M for the same period.
Quantum BioPharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 79% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $2.2M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Quantum BioPharma Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Exact Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Citius Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| DexTech Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Anebulo Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| AlzeCure Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Quantum BioPharma M&A Activity
Quantum BioPharma acquired XXX companies to date.
Last acquisition by Quantum BioPharma was on XXXXXXXX, XXXXX. Quantum BioPharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Quantum BioPharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialQuantum BioPharma Investment Activity
Quantum BioPharma invested in XXX companies to date.
Quantum BioPharma made its latest investment on XXXXXXXX, XXXXX. Quantum BioPharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Quantum BioPharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Quantum BioPharma
| When was Quantum BioPharma founded? | Quantum BioPharma was founded in 1994. |
| Where is Quantum BioPharma headquartered? | Quantum BioPharma is headquartered in Canada. |
| How many employees does Quantum BioPharma have? | As of today, Quantum BioPharma has over 7 employees. |
| Who is the CEO of Quantum BioPharma? | Quantum BioPharma's CEO is Zeeshan Saeed. |
| Is Quantum BioPharma publicly listed? | Yes, Quantum BioPharma is a public company listed on Nasdaq. |
| What is the stock symbol of Quantum BioPharma? | Quantum BioPharma trades under QNTM ticker. |
| When did Quantum BioPharma go public? | Quantum BioPharma went public in 2018. |
| Who are competitors of Quantum BioPharma? | Quantum BioPharma main competitors are Exact Therapeutics, Citius Pharmaceuticals, DexTech Medical, Anebulo Pharmaceuticals. |
| What is the current market cap of Quantum BioPharma? | Quantum BioPharma's current market cap is $19M. |
| Is Quantum BioPharma profitable? | No, Quantum BioPharma is not profitable. |
| What is the current net income of Quantum BioPharma? | Quantum BioPharma's last 12 months net income is ($22M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.